Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
Vicky SmithDebayan MukherjeeAnna Maria TsakiroglouAlexander R BakerHitesh MistryAnanya ChoudhuryPeter J HoskinTimothy M IllidgeCatharine M L WestPublished in: Cancers (2022)
MIBC with low CD8+ T cell counts may benefit from hypoxia-modifying treatment.